- We will send in 10–14 business days.
/images/books/12235154/9781788015103.jpg)
- Publisher: Royal Society of Chemistry
- ISBN-10: 178801510X
- ISBN-13: 9781788015103
- Format: 15.8 x 23.4 x 2.5 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Anti-Fibrotic Drug Discovery (e-book) (used book) | bookbook.eu
Reviews
Description
Fibrosis is a condition with globally high unmet medical need, and as such is a highly active area of academic and pharmaceutical research covering multiple treatment targets, organs, tissues and therapeutic approaches. Anti-fibrotic Drug Discovery is a single source reference for the latest drug-discovery approaches to tackle fibrosis in various tissues, comprehensively covering recent success and future perspectives on emerging therapeutic intervention points. The book highlights significant pre-clinical and clinical drugs currently being developed globally for this disorder. This book is ideal for postgraduate students and researchers with an interest in anti-fibrotic drug discovery as well as clinicians specialising in liver, kidney, heart and lung disease, in which fibrosis plays a key role in pathology.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 18d.09:04:44
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Royal Society of Chemistry
- ISBN-10: 178801510X
- ISBN-13: 9781788015103
- Format: 15.8 x 23.4 x 2.5 cm, hardcover
- Language: English English
Fibrosis is a condition with globally high unmet medical need, and as such is a highly active area of academic and pharmaceutical research covering multiple treatment targets, organs, tissues and therapeutic approaches. Anti-fibrotic Drug Discovery is a single source reference for the latest drug-discovery approaches to tackle fibrosis in various tissues, comprehensively covering recent success and future perspectives on emerging therapeutic intervention points. The book highlights significant pre-clinical and clinical drugs currently being developed globally for this disorder. This book is ideal for postgraduate students and researchers with an interest in anti-fibrotic drug discovery as well as clinicians specialising in liver, kidney, heart and lung disease, in which fibrosis plays a key role in pathology.
Reviews